Last reviewed · How we verify
NCT04855812: MyoMo in SCI
The Efficacy of Upper Extremity Wearable Robotic Orthosis on Improving Upper Extremity Motor Function and Activities of Daily Living in Persons With Spinal Cord Injury
NA trial testing MyoMo in SCI - Spinal Cord Injury in 15 participants. Completed in 30 September 2023.
30 September 2023
Quick facts
| Lead sponsor | Kessler Foundation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 27 October 2019 |
| Primary completion | 30 September 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MyoMo
- Myo-SB
- Control
Conditions studied
- SCI - Spinal Cord Injury — all drugs for SCI - Spinal Cord Injury →
Sponsor
Kessler Foundation
Who can join
Adults 18 to 80, any sex, with SCI - Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the usefulness of an upper extremity (UE) assistive device, called (MyoPro) in improving upper extremity activities in people with incomplete spinal cord injury (iSCI)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04855812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MyoMo
Trials testing the same drug.
- NCT06349434 — The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI · NA · recruiting
Other recruiting trials for SCI - Spinal Cord Injury
Currently open trials in the same condition.
- NCT07179588 — Nutrition and Pain Study · NA · active not recruiting
- NCT07052344 — Gut-Brain Neural Coupling in Spinal Cord Injury · NA · recruiting
- NCT05630235 — Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI · Phase 1, PHASE2 · recruiting
- NCT06999434 — Exploring the Utility of [18F]3F4AP for Demyelination Imaging · Phase 1 · recruiting
- NCT07106060 — Near-Infrared Imaging of Motor Imagery Effects in Spinal Cord Injury · NA · recruiting
Other Kessler Foundation trials
Trials by the same sponsor.
- NCT07168941 — Evaluation and Refinement of KF-STRIDE Into the Interview! · NA · not yet recruiting
- NCT07159100 — tDCS for Cancer-Related Fatigue and Weakness · EARLY_PHASE1 · not yet recruiting
- NCT06886152 — Spinal Stimulation and Gait Training to Improve Mobility in TBI · NA · not yet recruiting
- NCT07073313 — Using Muscle Functional MRI to Study Spatial Muscle Activation Patterns in People With SCI · not yet recruiting
- NCT06923293 — Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04855812 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kessler Foundation
- Last refreshed: 2 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04855812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing